| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 09/01/2009 | US7582440 Imaging, diagnosis and treatment of disease |
| 09/01/2009 | US7582436 Preparing oligonucleotides having a reduced number of 5' fragments; attaching 3-lipophilic end groups-containing oligonucleotides to a porous glass support; cleaving oligonuceotides to generate plurality of abasic ones; separation; purification; invasive cleavage reactions (INVADER assay) |
| 09/01/2009 | US7582435 Messenger RNA profiling: body fluid identification using multiplex reverse transcription-polymerase chain reaction (RT-PCR) |
| 09/01/2009 | US7582434 Corn event PV-ZMGT32(nk603) and compositions and methods for detection thereof |
| 09/01/2009 | US7582433 Apparatus which utilizes cyclic amplification of biopolymer sequences to detect adenoviral polynucleotides |
| 09/01/2009 | US7582432 Multiplexing methods using dark quenchers, nonfluorescing disazo dyes, functionalized for their rapid attachment to probe components; engineered to have a desired light absorption profile; facilitate interaction between quencher and fluorophore without form nucleic acid secondary structure |
| 09/01/2009 | US7582431 Using mismatch discriminative hybridization of short oligonucleotides to determine sequence for target nucleic acids |
| 09/01/2009 | US7582430 Immunoliposome-nucleic acid amplification (ILNAA) assay |
| 09/01/2009 | US7582429 Polymerase chain reaction analysis by mixing a dsDNA binding dye with a sample of target nucleic acid and primers configured for amplifying; melting the amplified target nucleic acid to generate a melting curve; plotting; repeating; comparison; melting curve difference for each target nucleic acid |
| 09/01/2009 | US7582428 Methods and compositions for identifying anti-HCV agents |
| 09/01/2009 | US7582427 Accurate detection of mutation in the exon 5 regions of isoforms 1-6 of uridine diphosphate glucuronosyl transferase (UGT) by determining the concentration of the product of 2-amino-5-nitro-4-trifluoromethylphenol drug glucuronidation; Crigler-Najjar, Gilbert , Dubin-Johnson, Rotor syndromes |
| 09/01/2009 | US7582426 Method for expression of proteins on spore surface |
| 09/01/2009 | US7582425 Identifying subjects who have or are at risk for developing Hereditary Spastic Paraplegia by detecting the presence or absence of one or more variations in the atlastin gene or treating HSP by administering atlastin |
| 09/01/2009 | US7582424 Genetic disorders and cholera endotoxins for calcium channel activators |
| 09/01/2009 | US7582423 Population of polynucleotide sequence variants |
| 09/01/2009 | US7582422 Modified carbon and germanium surfaces |
| 09/01/2009 | US7582421 Methods for determination of single nucleic acid polymorphisms using a bioelectronic microchip |
| 09/01/2009 | US7582420 Multiplex nucleic acid reactions |
| 09/01/2009 | US7582419 Electron transfer involving binding analyte to redox active complex that is a solvent accessible transition metal complex; self-assembling |
| 09/01/2009 | US7582418 Antimicrobial chelates |
| 09/01/2009 | US7582417 Sequential reporter enzyme luminescence (SRL) methods and compositions for practicing the same |
| 09/01/2009 | US7582416 Ligand for G-protein coupled receptor FPRL2 and uses thereof |
| 09/01/2009 | US7582415 Rapid detection of replicating cells |
| 09/01/2009 | US7582303 Hepatitis virus for use in the diagnosis and prevention of viral diseases in birds and humans; polynucleotide consisting of the nucleotide sequence of the ORF2 gene of an avian hepatitis E virus or its complementary strand |
| 09/01/2009 | US7582302 Needle-free administration of FeLV vaccines |
| 09/01/2009 | US7582282 Methods for optimizing clinical responsiveness to methotrexate therapy using metabolite profiling and pharmacogenetics |
| 09/01/2009 | US7582260 Zwitterionic dyes for labeling in proteomic and other biological analyses |
| 09/01/2009 | US7582259 Chip-shaped blood analysis device constituted by micro trench channels formed in an insulating substrate such as a quartz plate or a polymer resin plate; quick diagnosis of presence of an infectious disease (hepatitis, acquired immune deficiency syndrome, etc.) of the person being tested |
| 09/01/2009 | CA2412121C Method for the detection of influenza a/b viruses |
| 09/01/2009 | CA2375534C Use of the combing process for the identification of dna origins of replication |
| 09/01/2009 | CA2258561C Glyceraldehyde-3-phosphate dehydrogenase and nuclear restoration of cytoplasmic male sterility |
| 09/01/2009 | CA2163454C Regulation of plant growth |
| 09/01/2009 | CA2087614C Methods of identifying compounds that act as agonists or antagonists for proteins involved in signal transduction |
| 08/29/2009 | CA2621155A1 Stem cell expression cassettes |
| 08/27/2009 | WO2009105757A2 Methods and compositions for diagnosis of age-related macular degeneration |
| 08/27/2009 | WO2009105739A2 Dna detection by dna chip |
| 08/27/2009 | WO2009105718A1 Genetic alterations associated with autism and the autistic phenotype and methods of use thereof for the diagnosis and treatmemt of autism |
| 08/27/2009 | WO2009105680A2 Genetic polymorphisms associated with stroke, methods of detection and uses thereof |
| 08/27/2009 | WO2009105671A2 Methods and compositions related to peptides and proteins with c-terminal elements cross-reference to related applications |
| 08/27/2009 | WO2009105657A1 Compositions and methods for catalyzing dna-programmed chemistry |
| 08/27/2009 | WO2009105655A1 Methods and compositions for predicting success in addictive substance cessation and for predicting a risk of addiction |
| 08/27/2009 | WO2009105648A2 Systems and methods for point-of care amplification and detection of polynucleotides |
| 08/27/2009 | WO2009105640A1 Signatures associated with rejection or recurrence of cancer |
| 08/27/2009 | WO2009105592A2 Compositions and methods for detection of propionibacterium acnes nucleic acid |
| 08/27/2009 | WO2009105590A2 Identification of pediatric onset inflammatory bowel disease loci and methods of use thereof for the diagnosis and treatment of the same |
| 08/27/2009 | WO2009105583A1 Fluorescence resonance energy transfer (fret) binding assays that are surface-based |
| 08/27/2009 | WO2009105549A2 Detection and prognosis of lung cancer |
| 08/27/2009 | WO2009105543A1 A mutation in the regulatory region of gjb2 mediates neonatal hearing loss within dfnb1 |
| 08/27/2009 | WO2009105533A2 Methods for predicting esophageal adenocarcinoma (eac) |
| 08/27/2009 | WO2009105531A1 Methods for cell genotyping |
| 08/27/2009 | WO2009105520A2 Methods, devices, and compositions for the highly-sensitive detection and identification of diverse molecular entities |
| 08/27/2009 | WO2009105481A1 Mao-b elevation as an early parkinson's disease biomarker |
| 08/27/2009 | WO2009105457A2 Slit2 cancer markers |
| 08/27/2009 | WO2009105335A1 Methods and compositions for the diagnosis and treatment of acute lymphoblastic leukemia |
| 08/27/2009 | WO2009105223A1 Systems and methods of cancer staging and treatment |
| 08/27/2009 | WO2009105212A2 Detection of polyomavirus |
| 08/27/2009 | WO2009105154A2 Diagnostic and prognostic methods for cancer |
| 08/27/2009 | WO2009105077A2 Methods for preparing modified biomolecules, modified biomolecules and methods for using same |
| 08/27/2009 | WO2009105063A1 Systems and methods for identifying a culture as positive for microorganisms with high confidence |
| 08/27/2009 | WO2009105061A1 Systems and methods for presumptive identification of microorganism type in a culture |
| 08/27/2009 | WO2009104937A2 Optical gene code identification system using nanohybrid technology |
| 08/27/2009 | WO2009104926A1 Chip for hpv genotyping |
| 08/27/2009 | WO2009104741A1 Substrate for assaying β-glucan and/or endotoxin and assay method |
| 08/27/2009 | WO2009104730A1 Identification of hypertension susceptibility gene group |
| 08/27/2009 | WO2009104714A1 Early genetic test method for cancer |
| 08/27/2009 | WO2009104698A1 Cholesterol oxidase, chromobacterium sp. microbes, measurement reagent, testing method, gene coding for cholesterol oxidase, recombination vector, transformants, and cholesterol oxidase manufacturing method |
| 08/27/2009 | WO2009104641A1 Method of detecting and quantifying nematodes in soil and instrument for consolidating soil sample to be used therein |
| 08/27/2009 | WO2009104413A1 Method for screening of anti-cancer agent |
| 08/27/2009 | WO2009104388A1 Prophylactic/therapeutic agent for collagenosis |
| 08/27/2009 | WO2009104075A2 Methods of producing homogeneous plastic-adherent aptamer-magnetic bead-fluorophore and other sandwich assays |
| 08/27/2009 | WO2009104013A1 Covalently linked thermostable kinase for decontamination process validation |
| 08/27/2009 | WO2009103992A1 Genetic variation associated with coeliac disease |
| 08/27/2009 | WO2009103984A1 Cancer detection methods and techniques |
| 08/27/2009 | WO2009103790A2 Method and kit for the detection of genes associated with pik3ca mutation and involved in pi3k/akt pathway activation in the er-positive and her2-positive subtypes with clinical implications |
| 08/27/2009 | WO2009103784A1 BRCA1 mRNA EXPRESSION LEVELS PREDICT SURVIVAL IN BREAST CANCER PATIENTS TREATED WITH NEOADJUVANT CHEMOTHERAPY |
| 08/27/2009 | WO2009103781A1 Method for the prognosis of non-small cell lung cancer |
| 08/27/2009 | WO2009103779A1 BRCA1 mRNA EXPRESSION PREDICTS SURVIVAL IN PATIENTS WITH BLADDER CANCER TREATED WITH NEOADJUVANT CISPLATIN-BASED CHEMOTHERAPY |
| 08/27/2009 | WO2009103753A1 Methods for identifying and/or sorting cells by secreted molecule and kits for performing such methods |
| 08/27/2009 | WO2009103540A1 Stabilization of dehydrogenases using stable coenzymes |
| 08/27/2009 | WO2009103494A2 Sgk1 as a therapeutic and diagnostic target for carcinomatous diseases |
| 08/27/2009 | WO2009103197A1 A sensor for measuring the amount of an analyte in human tissue fluid, a fluid channel unit and a detecting method thereof |
| 08/27/2009 | WO2009103128A1 Detection of anti-parasitic compounds |
| 08/27/2009 | WO2009103110A1 Cell processing and/or enrichment methods |
| 08/27/2009 | WO2009085357A3 Microorganism concentration process |
| 08/27/2009 | WO2009085234A3 Use of micro-rna as a biomarker of immunomodulatory drug activity |
| 08/27/2009 | WO2009084960A3 Methylation detection in the genomic region of a receptor proteintyrosine phosphatase gamma gene for detection and/or diagnosis of a tumour |
| 08/27/2009 | WO2009077479A3 Altering high-density lipoprotein levels through carboxylesterase 1 modulation |
| 08/27/2009 | WO2009076651A9 Methods for identifying compounds that modulate lisch-like protein or c1orf32 protein activity and methods of use |
| 08/27/2009 | WO2009076485A9 Sequencing of nucleic acids |
| 08/27/2009 | WO2009073478A3 Tle3 as a marker for chemotherapy |
| 08/27/2009 | WO2009067473A3 Method of improving palliative care |
| 08/27/2009 | WO2009064789A3 Methods for detecting and monitoring circulating cancer stem cells |
| 08/27/2009 | WO2009062042A3 Methods and compositions for improved cattle longevity and milk production |
| 08/27/2009 | WO2009061641A3 Automated analyzer for clinical laboratory |
| 08/27/2009 | WO2009048873A3 Detection of atypical pneumonia |
| 08/27/2009 | WO2009046191A3 Microorganism concentration process and agent |
| 08/27/2009 | WO2009042209A3 Identification of thymically derived cd4 t cells by protein tyrosine kinase 7 expression |
| 08/27/2009 | WO2009037527A3 Methods, systems, and compositions for cancer diagnosis |
| 08/27/2009 | WO2009036525A3 Tools and methods for genetic tests using next generation sequencing |
| 08/27/2009 | WO2009036100A3 Prediction of qt prolongation based on snp genotype |